ロード中...
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model
The transcription factor NF-κB promotes survival of cancer cells exposed to doxorubicin and other chemotherapeutic agents. IκB kinase is essential for chemotherapy-induced NF-κB activation and considered a prime target for anticancer treatment. An IκB kinase inhibitor sensitized human melanoma xenog...
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2011
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3290412/ https://ncbi.nlm.nih.gov/pubmed/22389871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0143 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|